1	Lymphocytes	Lymphocyte	_	_	_	_	_	_	_
2	from	from	_	_	_	_	_	_	_
3	CML	CML	_	_	_	_	_	_	_
4	patients	patient	_	_	_	_	_	_	_
5	lack	lack	_	_	_	_	_	_	_
6	a	a	_	_	_	_	_	_	_
7	47	47	_	_	_	_	_	_	_
8	kDa	kda	_	_	_	_	_	_	_
9	factor	factor	_	_	_	_	_	_	_
10	having	have	_	_	_	_	_	_	_
11	affinity	affinity	_	_	_	_	_	_	_
12	for	for	_	_	_	_	_	_	_
13	a	a	_	_	_	_	_	_	_
14	genomic	genomic	_	_	_	_	_	_	_
15	sterol	sterol	_	_	_	_	_	_	_
16	regulatory	regulatory	_	_	_	_	_	_	_
17	sequence	sequence	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	Deranged	deranged	_	_	_	_	_	_	_
2	cellular	cellular	_	_	_	_	_	_	_
3	cholesterol	cholesterol	_	_	_	_	_	_	_
4	homeostasis	homeostasis	_	_	_	_	_	_	_
5	has	have	_	_	_	_	_	_	_
6	been	be	_	_	_	_	_	_	_
7	widely	widely	_	_	_	_	_	_	_
8	recognized	recognize	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	initiation	initiation	_	_	_	_	_	_	_
12	as	as	_	_	_	_	_	_	_
13	well	well	_	_	_	_	_	_	_
14	as	as	_	_	_	_	_	_	_
15	progression	progression	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	various	various	_	_	_	_	_	_	_
18	types	type	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	cancers	cancer	_	_	_	_	_	_	_
21	including	include	_	_	_	_	_	_	_
22	chronic	chronic	_	_	_	_	_	_	_
23	myeloid	myeloid	_	_	_	_	_	_	_
24	leukaemia	leukaemia	_	_	_	_	_	_	_
25	(	(	_	_	_	_	_	_	_
26	CML	CML	_	_	_	_	_	_	_
27	)	)	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

1	Since	since	_	_	_	_	_	_	_
2	the	the	_	_	_	_	_	_	_
3	human	human	_	_	_	_	_	_	_
4	genomic	genomic	_	_	_	_	_	_	_
5	sterol	sterol	_	_	_	_	_	_	_
6	regulatory	regulatory	_	_	_	_	_	_	_
7	element	element	_	_	_	_	_	_	_
8	(	(	_	_	_	_	_	_	_
9	SRE	SRE	_	_	_	_	_	_	_
10	)	)	_	_	_	_	_	_	_
11	has	have	_	_	_	_	_	_	_
12	been	be	_	_	_	_	_	_	_
13	shown	show	_	_	_	_	_	_	_
14	to	to	_	_	_	_	_	_	_
15	regulate	regulate	_	_	_	_	_	_	_
16	various	various	_	_	_	_	_	_	_
17	key	key	_	_	_	_	_	_	_
18	genes	gene	_	_	_	_	_	_	_
19	involved	involve	_	_	_	_	_	_	_
20	in	in	_	_	_	_	_	_	_
21	this	this	_	_	_	_	_	_	_
22	phenomenon	phenomenon	_	_	_	_	_	_	_
23	,	,	_	_	_	_	_	_	_
24	the	the	_	_	_	_	_	_	_
25	present	present	_	_	_	_	_	_	_
26	study	study	_	_	_	_	_	_	_
27	revealed	reveal	_	_	_	_	_	_	_
28	the	the	_	_	_	_	_	_	_
29	existence	existence	_	_	_	_	_	_	_
30	of	of	_	_	_	_	_	_	_
31	a	a	_	_	_	_	_	_	_
32	unique	unique	_	_	_	_	_	_	_
33	47	47	_	_	_	_	_	_	_
34	kDa	kda	_	_	_	_	_	_	_
35	protein	protein	_	_	_	_	_	_	_
36	factor	factor	_	_	_	_	_	_	_
37	having	have	_	_	_	_	_	_	_
38	affinity	affinity	_	_	_	_	_	_	_
39	for	for	_	_	_	_	_	_	_
40	this	this	_	_	_	_	_	_	_
41	SRE	SRE	_	_	_	_	_	_	_
42	sequence	sequence	_	_	_	_	_	_	_
43	in	in	_	_	_	_	_	_	_
44	lymphocytes	lymphocyte	_	_	_	_	_	_	_
45	from	from	_	_	_	_	_	_	_
46	normal	normal	_	_	_	_	_	_	_
47	subjects	subject	_	_	_	_	_	_	_
48	,	,	_	_	_	_	_	_	_
49	as	as	_	_	_	_	_	_	_
50	well	well	_	_	_	_	_	_	_
51	as	as	_	_	_	_	_	_	_
52	its	its	_	_	_	_	_	_	_
53	absence	absence	_	_	_	_	_	_	_
54	in	in	_	_	_	_	_	_	_
55	lymphocytes	lymphocyte	_	_	_	_	_	_	_
56	from	from	_	_	_	_	_	_	_
57	untreated	untreated	_	_	_	_	_	_	_
58	CML	CML	_	_	_	_	_	_	_
59	patients	patient	_	_	_	_	_	_	_
60	.	.	_	_	_	_	_	_	_

1	However	however	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	this	this	_	_	_	_	_	_	_
4	factor	factor	_	_	_	_	_	_	_
5	appeared	appear	_	_	_	_	_	_	_
6	when	when	_	_	_	_	_	_	_
7	these	these	_	_	_	_	_	_	_
8	CML	CML	_	_	_	_	_	_	_
9	patients	patient	_	_	_	_	_	_	_
10	achieved	achieve	_	_	_	_	_	_	_
11	complete	complete	_	_	_	_	_	_	_
12	haematological	haematological	_	_	_	_	_	_	_
13	remission	remission	_	_	_	_	_	_	_
14	(	(	_	_	_	_	_	_	_
15	CHR	CHR	_	_	_	_	_	_	_
16	)	)	_	_	_	_	_	_	_
17	through	through	_	_	_	_	_	_	_
18	alpha-interferon	alpha-interferon	_	_	_	_	_	_	_
19	therapy	therapy	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	Furthermore	furthermore	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	an	an	_	_	_	_	_	_	_
4	inverse	inverse	_	_	_	_	_	_	_
5	relationship	relationship	_	_	_	_	_	_	_
6	was	be	_	_	_	_	_	_	_
7	also	also	_	_	_	_	_	_	_
8	observed	observe	_	_	_	_	_	_	_
9	between	between	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	LDL	LDL	_	_	_	_	_	_	_
12	receptor	receptor	_	_	_	_	_	_	_
13	gene	gene	_	_	_	_	_	_	_
14	expression	expression	_	_	_	_	_	_	_
15	at	at	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	transcriptional	transcriptional	_	_	_	_	_	_	_
18	level	level	_	_	_	_	_	_	_
19	and	and	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	binding	binding	_	_	_	_	_	_	_
22	affinity	affinity	_	_	_	_	_	_	_
23	of	of	_	_	_	_	_	_	_
24	this	this	_	_	_	_	_	_	_
25	47	47	_	_	_	_	_	_	_
26	kDa	kda	_	_	_	_	_	_	_
27	protein	protein	_	_	_	_	_	_	_
28	factor	factor	_	_	_	_	_	_	_
29	to	to	_	_	_	_	_	_	_
30	the	the	_	_	_	_	_	_	_
31	SRE	SRE	_	_	_	_	_	_	_
32	sequence	sequence	_	_	_	_	_	_	_
33	.	.	_	_	_	_	_	_	_

1	Based	base	_	_	_	_	_	_	_
2	upon	upon	_	_	_	_	_	_	_
3	these	these	_	_	_	_	_	_	_
4	results	result	_	_	_	_	_	_	_
5	we	we	_	_	_	_	_	_	_
6	propose	propose	_	_	_	_	_	_	_
7	that	that	_	_	_	_	_	_	_
8	this	this	_	_	_	_	_	_	_
9	factor	factor	_	_	_	_	_	_	_
10	may	may	_	_	_	_	_	_	_
11	have	have	_	_	_	_	_	_	_
12	a	a	_	_	_	_	_	_	_
13	role	role	_	_	_	_	_	_	_
14	in	in	_	_	_	_	_	_	_
15	pathophysiology	pathophysiology	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	chronic	chronic	_	_	_	_	_	_	_
18	myeloid	myeloid	_	_	_	_	_	_	_
19	leukaemia	leukaemia	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

